MedPath

Hypoglycemia and Autonomic Nervous System Function

Not Applicable
Completed
Conditions
Hypoglycemia
Interventions
Other: Euglycemic hyperinsulinemic clamp
Other: Hypoglycemic hyperinsulinemic clamp
Registration Number
NCT01816893
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

The goals of this proposal are to determine the effects of hypoglycemia on the autonomic nervous system.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Euglycemic hyperinsulinemic clampEuglycemic hyperinsulinemic clampparticipant undergoes a euglycemic hyperinsulinemic clamp
Hypoglycemic hyperinsulinemic clampHypoglycemic hyperinsulinemic clampparticipant undergoes a hypoglycemic hyperinsulinemic clamp
Primary Outcome Measures
NameTimeMethod
Change in Baroreflex Sensitivity16 hours after euglycemic and hypoglycemic clamps as compared to baseline

The change in baroreflex sensitivity (milliseconds/mm Hg) is calculated as baroreflex sensitivity (milliseconds/mm Hg) on day 3 \[assessed 16 hours after the clamp\] minus baroreflex sensitivity (milliseconds/mm Hg) on day 1 \[baseline assessment on the day prior to the clamp\]). Change in baroreflex sensitivity in euglycemic clamp arm is compared to change in baroreflex sensitivity in hypoglycemic arm.

Secondary Outcome Measures
NameTimeMethod
Muscle Sympathetic Nerve Activity16 hours after euglycemic and hypoglycemic clamps

Muscle sympathetic nerve activity (MSNA), at rest and immediately after nitroprusside, was measured on Day 3 about 16 hours after the euglycemic and hypoglycemic clamps.

Catecholamine Response to Lower-body Negative Pressure16 hours after euglycemic and hypoglycemic clamps

Plasma norepinephrine response to lower body negative pressure (at the minus 40 mm Hg data point) on Day 3 about 16 to 20 hours after completion of the euglycemic or hypoglycemic clamp.

Trial Locations

Locations (2)

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath